Influência da utilização de cepas de T. cruzi dos grupos TCI, TCII e Z3, na performance imunodiagnóstica da doença de Chagas no Brasil e no Panamá by Espinosa, Zuleima del C. Caballero
Rev. Inst. Med. trop. S. Paulo
49(1):48, January-February, 2007
*This thesis is available at the Library of the Instituto de Medicina Tropical de São Paulo
SUMMARY OF THESIS*
CABALLERO ESPINOSA, Zuleima del C. - Influência da utilização de cepas de T. cruzi dos grupos TCI, TCII e Z3, na performance
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INFLUENCE OF GROUPS OF T. cruzi TcI, TcII AND Z3 IN THE DIAGNOSTIC PERFORMANCE OF
CHAGAS DISEASE IN BRAZIL AND PANAMÁ
T. cruzi, the agent of Chagas disease, could be classified within
two major lineages, T. cruzi Group I (TcI) and T. cruzi Group II (TcII)
and Z3, presenting differences in several biochemical and biological
aspects. Genetic markers, which allow typing of T. cruzi, showed that
the two major groups have different phylogenetic origin that co-evoluted
in different ecological and epidemiological traits. The bulk of these
results stimulated investigations regarding to possible association of
T. cruzi groups with human infection and serological titers. This project
aims to analyze the sensitivity and specificity of ELISA and TESA-
blot, performed with strains of T.cruzi TcI, TcII and Z3 as antigens
[total extract of epimastigote forms (EAE) or exoantigens of
trypomastigote forms (TESA)]. A sensitivity of 100% and specificity
of 74.5% - 84.2% were obtained in EAE-ELISAs, with 154 analyzed
samples. Cross-reaction of 71 - 100% were presented by Leishmania
spp. infected individuals and 9% to 28% by T. rangeli. In a
seroprevalence study performed in Mendoza-Panama, TESA-blot (a
reference test) as well as EAE-ELISAs showed positivity of 13.3%
(16/120). In this study were included the analyses of six commercially
available ELISAs, whose only two showed a positivity of 13.3%. The
sensitivity data led us to conclude, that tests for diagnosis of Chagas
disease can be performed with non regional strain. T. rangeli infected
patients seems to have no antibodies against  T. cruzi or T. rangeli
antigens, so these patients present no problem in the Chagas disease
diagnosis.
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